- Home
- CTMX vs SFWL Comparison
CTMX vs SFWL Comparison
Compare CTMX & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- SFWL
- Stock Information
- Founded
- CTMX 2008
- SFWL 2001
- Country
- CTMX United States
- SFWL China
- Employees
- CTMX N/A
- SFWL N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- SFWL Trucking Freight/Courier Services
- Sector
- CTMX Health Care
- SFWL Industrials
- Exchange
- CTMX Nasdaq
- SFWL Nasdaq
- Market Cap
- CTMX 62.3M
- SFWL 80.8M
- IPO Year
- CTMX 2015
- SFWL 2023
- Fundamental
- Price
- CTMX $0.80
- SFWL $1.01
- Analyst Decision
- CTMX Buy
- SFWL
- Analyst Count
- CTMX 6
- SFWL 0
- Target Price
- CTMX $5.77
- SFWL N/A
- AVG Volume (30 Days)
- CTMX 731.5K
- SFWL 21.7K
- Earning Date
- CTMX 03-10-2025
- SFWL 03-27-2025
- Dividend Yield
- CTMX N/A
- SFWL N/A
- EPS Growth
- CTMX N/A
- SFWL N/A
- EPS
- CTMX 0.16
- SFWL 0.11
- Revenue
- CTMX $126,617,000.00
- SFWL $446,281,000.00
- Revenue This Year
- CTMX $22.55
- SFWL N/A
- Revenue Next Year
- CTMX N/A
- SFWL N/A
- P/E Ratio
- CTMX $4.93
- SFWL $9.37
- Revenue Growth
- CTMX 33.66
- SFWL 14.80
- 52 Week Low
- CTMX $0.75
- SFWL $0.81
- 52 Week High
- CTMX $5.85
- SFWL $2.23
- Technical
- Relative Strength Index (RSI)
- CTMX 41.61
- SFWL 46.13
- Support Level
- CTMX $0.75
- SFWL $0.98
- Resistance Level
- CTMX $0.98
- SFWL $1.06
- Average True Range (ATR)
- CTMX 0.06
- SFWL 0.04
- MACD
- CTMX 0.00
- SFWL 0.01
- Stochastic Oscillator
- CTMX 20.13
- SFWL 44.00
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. The company offers contract logistics services comprising planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The integrated logistics solution services of the company are comprised of three segments: B2B freight transportation; cloud storage; and value-added services.